Current Perspectives and Future Prospects of mRNA Vaccines against Viral Diseases: A Brief Review

被引:4
作者
Koppu, Vasavi [1 ]
Poloju, Deepa [1 ]
Puvvala, Bhavani [1 ]
Madineni, Kavitha [1 ]
Balaji, Shilpa [1 ]
Sheela, Chandana Muraleedharan Pillai [1 ]
Manchikanti, Sri Sai Charan [1 ]
Moon, Satpathy Moon [1 ]
机构
[1] ICAR IVRI, Dept Vet Microbiol, Bareilly, Uttar Pradesh, India
关键词
mRNA; vaccine; virus; lipid nanoparticle; codon optimization; LIPID NANOPARTICLES; IN-VIVO; DELIVERY; CELLS;
D O I
10.22088/IJMCM.BUMS.11.3.260
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The mRNA vaccines replace our conventional vaccines (live-attenuated and inactivated vaccines) due to their high safety, efficacy, potency and low cost for their manufacturing. Since these many years, the use of these mRNA vaccines has been restricted as they are unstable and their low efficiency in in-vivo delivery. But now, these problems have been solved by recent technological advances. Many studies conducted in animal models and humans demonstrated the good results for the mRNA vaccines. This review provides you a detailed overview of mRNA viral vaccines and considers the current perspectives and future prospects.
引用
收藏
页码:260 / 272
页数:13
相关论文
共 41 条
[1]   Mucosal immune response in BNT162b2 COVID-19 vaccine recipients [J].
Azzi, Lorenzo ;
Dalla Gasperina, Daniela ;
Veronesi, Giovanni ;
Shallak, Mariam ;
Ietto, Giuseppe ;
Iovino, Domenico ;
Baj, Andreina ;
Gianfagna, Francesco ;
Maurino, Vittorio ;
Focosi, Daniele ;
Maggi, Fabrizio ;
Ferrario, Marco Mario ;
Dentali, Francesco ;
Carcano, Giulio ;
Tagliabue, Angelo ;
Maffioli, Lorenzo Stefano ;
Accolla, Roberto Sergio ;
Forlani, Greta .
EBIOMEDICINE, 2022, 75
[2]   Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection [J].
Batty, Cole J. ;
Heise, Mark T. ;
Bachelder, Eric M. ;
Ainslie, Kristy M. .
ADVANCED DRUG DELIVERY REVIEWS, 2021, 169 :168-189
[3]   MICROINJECTION OF RABBIT HEMOGLOBIN MESSENGER-RNA INTO AMPHIBIAN OOCYTES AND EMBRYOS [J].
BRACHET, J ;
HUEZ, G ;
HUBERT, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (02) :543-547
[4]   Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation [J].
Coolen, Anne-Line ;
Lacroix, Celine ;
Mercier-Gouy, Perrine ;
Delaune, Emilie ;
Monge, Claire ;
Exposito, Jean-Yves ;
Verrier, Bernard .
BIOMATERIALS, 2019, 195 :23-37
[5]   Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines [J].
Demoulins, Thomas ;
Milona, Panagiota ;
Englezou, Pavlos C. ;
Ebensen, Thomas ;
Schulze, Kai ;
Suter, Rolf ;
Pichon, Chantal ;
Midoux, Patrick ;
Guzman, Carlos A. ;
Ruggli, Nicolas ;
McCullough, Kenneth C. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (03) :711-722
[6]   The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation [J].
Ding, Yuanyuan ;
Guo, Zhenhong ;
Liu, Yiqi ;
Li, Xia ;
Zhang, Qian ;
Xu, Xiongfei ;
Gu, Yan ;
Zhang, Yi ;
Zhao, Dezhi ;
Cao, Xuetao .
NATURE IMMUNOLOGY, 2016, 17 (10) :1167-+
[7]   Dendritic cell subsets in T cell programming: location dictates function [J].
Eisenbarth, S. C. .
NATURE REVIEWS IMMUNOLOGY, 2019, 19 (02) :89-103
[8]   CATIONIC LIPOSOME-MEDIATED TRANSFECTION [J].
FELGNER, PL ;
RINGOLD, GM .
NATURE, 1989, 337 (6205) :387-388
[9]   Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine [J].
Francavilla, Beatrice ;
Nuccetelli, Marzia ;
Guerrieri, Mariapia ;
Fiorelli, Denise ;
Di Girolamo, Stefano .
EBIOMEDICINE, 2022, 79
[10]   Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection [J].
Guerrieri, Mariapia ;
Francavilla, Beatrice ;
Fiorelli, Denise ;
Nuccetelli, Marzia ;
Passali, Francesco Maria ;
Coppeta, Luca ;
Somma, Giuseppina ;
Bernardini, Sergio ;
Magrini, Andrea ;
Di Girolamo, Stefano .
VACCINES, 2021, 9 (12)